User profiles for Gianluca Campo

Gianluca Campo

UO Cardiologia, Azienda Ospedaliera di Ferrara
Verified email at unife.it
Cited by 18904

Short physical performance battery and all-cause mortality: systematic review and meta-analysis

…, A Corsonello, GD Kirk, R Ferrari, S Volpato, G Campo - BMC medicine, 2016 - Springer
Background The Short Physical Performance Battery (SPPB) is a well-established tool to
assess lower extremity physical performance status. Its predictive ability for all-cause mortality …

Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury

…, R Pavasini, MR Wieckowski, G Campo… - Journal of molecular and …, 2015 - Elsevier
The mitochondrial permeability transition is a key event in cell death. Intense research
efforts have been focused on elucidating the molecular components of the mitochondrial …

Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management

G Campo, R Pavasini, M Malagù, S Mascetti… - … drugs and therapy, 2015 - Springer
In the last few years, many studies focused their attention on the relationship between chronic
obstructive pulmonary disease (COPD) and ischemic heart disease (IHD), showing that …

Bioresorbable scaffold vs. second generation drug eluting stent in long coronary lesions requiring overlap: a propensity-matched comparison (the UNDERDOGS study …

…, P Capasso, C Di Mario, S Brugaletta, G Campo - International journal of …, 2016 - Elsevier
Background Randomized clinical trials on bioresorbable scaffolds (BRS) enrolled patients
with simple coronary lesions. The present study was sought to give preliminary findings about …

[HTML][HTML] Complete or culprit-only PCI in older patients with myocardial infarction

…, E Barbato, M Tebaldi, G Campo - … England Journal of …, 2023 - Mass Medical Soc
Background The benefit of complete revascularization in older patients (≥75 years of age)
with myocardial infarction and multivessel disease remains unclear. Methods In this …

Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy

…, A Saglietto, GG Secco, G Campo… - … England Journal of …, 2020 - Mass Medical Soc
Acute Coronary Syndrome during Covid-19 Outbreak During the Covid-19 outbreak in
northern Italy, the daily rate of admissions for acute coronary syndrome at 15 hospitals was …

Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial

M Valgimigli, G Campo, M Monti, P Vranckx… - Circulation, 2012 - Am Heart Assoc
Background— The optimal duration of dual-antiplatelet therapy and the risk-benefit ratio for
long-term dual-antiplatelet therapy after coronary stenting remain poorly defined. We …

[HTML][HTML] Five-year outcomes with PCI guided by fractional flow reserve

…, A Irimpen, K Oldroyd, G Campo… - … England Journal of …, 2018 - Mass Medical Soc
Background We hypothesized that fractional flow reserve (FFR)–guided percutaneous
coronary intervention (PCI) would be superior to medical therapy as initial treatment in patients …

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a …

…, T Lewalter, G Gargiulo, V Batushkin, G Campo… - The Lancet, 2019 - thelancet.com
Background We aimed to assess the safety of edoxaban in combination with P2Y12
inhibition in patients with atrial fibrillation who had percutaneous coronary intervention (PCI). …

[HTML][HTML] Complete revascularization with multivessel PCI for myocardial infarction

…, N Pinilla-Echeverri, R Moreno, G Campo… - … England Journal of …, 2019 - Mass Medical Soc
Background In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous
coronary intervention (PCI) of the culprit lesion reduces the risk of cardiovascular death …